Share on StockTwits

CVS Caremark Corp. (NYSE:CVS) EVP Per Gh Lofberg sold 790,888 shares of CVS Caremark Corp. stock on the open market in a transaction that occurred on Friday, January 3rd. The shares were sold at an average price of $70.54, for a total value of $55,789,239.52. Following the completion of the sale, the executive vice president now directly owns 219,871 shares in the company, valued at approximately $15,509,700. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.

Shares of CVS Caremark Corp. (NYSE:CVS) traded up 0.21% on Friday, hitting $70.55. The stock had a trading volume of 3,885,814 shares. CVS Caremark Corp. has a 52-week low of $49.44 and a 52-week high of $71.99. The stock’s 50-day moving average is $67.99 and its 200-day moving average is $61.76. The company has a market cap of $84.942 billion and a price-to-earnings ratio of 19.62.

CVS Caremark Corp. (NYSE:CVS) last issued its quarterly earnings data on Tuesday, November 5th. The company reported $1.05 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.02 by $0.03. The company had revenue of $32.00 billion for the quarter, compared to the consensus estimate of $31.53 billion. During the same quarter last year, the company posted $0.85 earnings per share. CVS Caremark Corp.’s revenue was up 5.8% compared to the same quarter last year. Analysts expect that CVS Caremark Corp. will post $3.96 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which is scheduled for Monday, February 3rd. Shareholders of record on Thursday, January 23rd will be paid a dividend of 0.275 per share. This represents a $1.10 annualized dividend and a dividend yield of 1.56%. The ex-dividend date is Tuesday, January 21st. This is a positive change from CVS Caremark Corp.’s previous quarterly dividend of $0.23.

A number of research firms have recently commented on CVS. Analysts at Deutsche Bank reiterated a “hold” rating on shares of CVS Caremark Corp. in a research note to investors on Friday, December 20th. They now have a $76.00 price target on the stock, up previously from $71.00. Separately, analysts at JPMorgan Chase & Co. raised their price target on shares of CVS Caremark Corp. to $82.00 in a research note to investors on Thursday, December 19th. They now have an “overweight” rating on the stock. Finally, analysts at Argus raised their price target on shares of CVS Caremark Corp. from $70.00 to $77.00 in a research note to investors on Thursday, December 19th. They now have a “buy” rating on the stock. Eight investment analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $73.00.

CVS Caremark Corporation (NYSE:CVS), together with its subsidiaries, is a pharmacy health care provider in the United States.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.